Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate this contract at its sole option upon 14 calendar days’ written notice to Buyer. 24.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate this contract at its sole option upon 14 calendar days’ written notice to Buyer. 24.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate this contract at its sole option upon 14 calendar days’ written notice to Buyer. 25.

สญัญาทั7งหมด ขอ้กาํหนดและเงื(อนไขเหล่านี7 ใชบ้งัคบักบัการขายสินคา้ทั7 งหมดโดยโพลีวนั คอรป์อเรชั (น และบริษัทในเครือ ขอ้ตกลงทั7งหมด ไม่วา่โดยวาจา หรอืเป็นลายลกัษณอ์กัษร ที(ไดท้าํขึ7 นไวก้อ่น หรือในขณะที(ลงนามในสญัญานี7 จะไม่มีผลเป็นการเปลี(ยนแปลง หรือแกไ้ขขอ้กาํหนดที(ระบุไวเ้ป็นลายลกัษณอ์กัษรในสญัญานี7 และคู่สญัญาจะไม่อา้งการแกไ้ข เปลี(ยนแปลง หรือปลดเปลื7 องจากเงื(อนไขใดๆ ในสญัญานี7 เวน้แต่การเปลี(ยนแปลงนั7นจะไดก้ระทําเป็นหนังสือ ลงนามโดยคู่สญัญาอีกฝ่ายหนึ(ง และระบุไวโ้ดยเฉพาะวา่เป็นการแกไ้ขเพิ(มเติมสญัญานี7 การที(ผูข้ายรบัทราบ หรือยอมรบัคาํสั (งซื7 อ คาํรบัรอง การปลดเปลื7 อง หรือเอกสารในรปูแบบอื(นใดที(ผูซื้7 อไดยื้(นใหแ้กผู่ข้าย โดยระบุขอ้กาํหนด หรือเงื(อนไขเพิ(มเติม หรือที(แตกต่างไปจากสญัญานี7 ไมถื่อเป็นการแกไ้ข หรือเพิ(มเติมสญัญานี7 แต่อยา่งใด และโดยสญัญานี7 ผูข้ายแจง้ใหผู้ซื้7 อทราบวา่ ผูข้ายปฏิเสธขอ้กาํหนด และเงื(อนไขเพิ(มเติมดงักล่าวทุกประการ เงื(อนไขที(ระบุไวที้(อื(นในสญัญานี7 ที(ขดั แยง้กบัเงื(อนไขที(ระบุไวใ้นขอ้กาํหนดและเงื(อนไขทั(วไป ใหใ้ชเ้งื(อนไขที(ระบุไวท้ี(อื(นนั7นเป็นเกณฑ ์ 14. The United Nations Convention respecting Contracts for the International Sale of Goods shall not apply to transactions under this contract. 14.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate the contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate (opzeggen) the contract at its sole option upon 14 calendar days’ written notice to Buyer. 24.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate this contract at its sole option upon 14 calendar days’ written notice to Buyer. 24.

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S 20% Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target A dj us te d Ea rn in gs P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra ti ng In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of 31 de diciembre de 2013 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of 31 de diciembre de 2013 Free Cash Flow and Strong Balance Sheet Fund Investment • Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin • Synergy opportunities • Adjacent material solutions • Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) • Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne? Strong past performance demonstrates that our strategy and execution are working • Megatrends align with our strengths • Innovation and services provide differentiation, incremental pricing power, and competitive advantage • Strong and proven management team driving growth and performance • Addressable market exceeds $40 billion Page 14 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate the purchase contract without further obligation upon: (i) 10 calendar days’ written notice commencing on the day following the date of delivery of the termination notice to the Seller; and (ii) payment for all Product received to date. 14. Seller may terminate a purchase contract and/or a framework contract at its sole option upon 14 calendar days’ written notice to Buyer.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate this contract at its sole option upon 14 calendar days’ written notice to Buyer. 24.

Except in the case of a force majeure, if not satisfied with Seller’s determination, Buyer as its sole remedy shall have a right to terminate this contract without further obligation upon: (i) 10 calendar days’ written notice; and (ii) payment for all Product received to date. 14. Seller may terminate this contract at its sole option upon 14 calendar days’ written notice to Buyer. 25.